Why the study?
Does elevated IL-6 predict mortality and hospital admission in ambulatory elderly patients with stable heart failure?
Does elevated IL-6 predict mortality and hospital admission in ambulatory elderly patients with stable heart failure?
Elevated IL-6 may serve as a prognostic factor for mortality and hospital admission in elderly patients with stable heart failure.
Elevated IL-6 may flag higher mortality risk in stable HF; hypothesis-generating for prognostication, needs prospective validation before clinical use.
Patients with heart failure and elevated IL-6 most often have atrial fibrillation, diabetes mellitus, dyslipidemia, anemia, and renal failure. In addition, mortality was higher and a tendency of higher hospital admission was observed in stable HF patients with elevated IL-6.
No takes yet. Share an insight, caveat, or question.
Povar-Echeverría et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: